Hematopoietic Stem and Progenitor Cell Mobilization in Mice and Humans by a First-in-Class Mirror-Image Oligonucleotide Inhibitor of CXCL12-Reference-Cited by-同舟云学术

Hematopoietic Stem and Progenitor Cell Mobilization in Mice and Humans by a First-in-Class Mirror-Image Oligonucleotide Inhibitor of CXCL12

Published:2013-03-19 Issue:1 Volume:94 Page:150-157
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:
Short-container-title:Clin Pharmacol Ther

Author:

Vater A,Sahlmann J,Kröger N,Zöllner S,Lioznov M,Maasch C,Buchner K,Vossmeyer D,Schwoebel F,Purschke W G,Vonhoff S,Kruschinski A,Hübel K,Humphrey M,Klussmann S,Fliegert F

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Reference30 articles.

1. Molecular cloning and structure of a pre-B-cell growth-stimulating factor.

2. Hypoxia- and Vascular Endothelial Growth Factor-Induced Stromal Cell-Derived Factor-1α/CXCR4 Expression in Glioblastomas

3. Trafficking of Normal Stem Cells and Metastasis of Cancer Stem Cells Involve Similar Mechanisms: Pivotal Role of the SDF‐1–CXCR4 Axis

4. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice

5. The Chemokine SDF-1 Is a Chemoattractant for Human CD34+ Hematopoietic Progenitor Cells and Provides a New Mechanism to Explain the Mobilization of CD34+ Progenitors to Peripheral Blood

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Applications of Aptamers;International Journal of Molecular Sciences;2024-06-19

2. L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trial;Nature Communications;2024-05-28

3. Aptamer-based therapy for fighting biofilm-associated infections;Journal of Controlled Release;2024-03

4. GPC-100, a novel CXCR4 antagonist, improves in vivo hematopoietic cell mobilization when combined with propranolol;PLOS ONE;2023-10-25

5. Aptamer-Based Immune Drug Systems (AptIDCs) Potentiating Cancer Immunotherapy;Chemistry;2023-07-30